MADRX Mutual Fund

MADRX Mutual Fund

NAV$26.61
See how much of MADRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$2M
Expense Ratio
0.73%
Dividend Yield (Current)
11.22%
Holdings
37
Inception Date
Feb 28, 2022
Fund Family
Madison Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly
SEC 30-Day Yield
PRO

Performance

YTD+11.31%
1 Year+15.96%
3 Year+9.12%
5 Year+6.23%
10 Year+9.79%

Asset Allocation

Stocks: 98.53%
Cash: 1.47%
See how much of MADRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
JNJJohnson & Johnson - Common5.28%
XOMExxon Mobil Corp.4.80%
CVXChevron Corp4.72%
NEENextera Energy Inc3.80%
CMECme Group, Cl A3.55%
Top 10 Concentration: 39.19%Report Date: Jul 31, 2026
Download all 37 holdings for MADRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
11.22%
Frequency
Quarterly

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MADRX Mutual Fund Overview

MADRX Mutual Fund (Madison Dividend Income Fund Class R6) is managed by Madison Funds with $2.1M in net assets. MADRX expense ratio is 0.73%, holding 37 positions across sectors including Financials, Industrials, Energy. Inception date: 2022-02-28.

MADRX performance shows a YTD return of 11.31%. The 1-year return is 15.96% and the 5-year return is 6.23%. MADRX dividend yield stands at 11.22%, paid quarterly.

MADRX top holdings include Johnson & Johnson - Common (5.3%), Exxon Mobil Corp. (4.8%), Chevron Corp (4.7%), Nextera Energy Inc (3.8%), Cme Group, Cl A (3.5%). Go to all MADRX holdings, MADRX sectors, or MADRX dividends.

MADRX can be compared against other funds. Use MADRX overlap to find shared positions, or MADRX vs another fund for a side-by-side view. MADRX alternatives are available via the screener, along with tax-loss harvesting opportunities.